TK216-vincristine combination for Ewing sarcoma identified5 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
Adam Rutherford to speak at Lab Innovations 20175 October 2017 | By Lab Innovations 2017Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017.
Alcohol aversion drug disulfiram may combat chemotherapy resistance5 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
Datwyler’s future-proof health care strategy4 October 2017 | By Datwyler Group• Datwyler Sealing Solutions presents the company’s new health care offering at CPhI Worldwide • First Line – Manufacturing concept for high-quality elastomer components
Computer model shows an optimal anti-amyloid treatment2 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)A group of scientists have created a computer model to analyse amyloid beta accumulation using published papers and clinical studies...
BioCompute specifications to advance genomic data analysis2 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Leading organisations have developed specifications, which will promote more streamline and reproducible bioinformatics research for clinical trials...
Parkinson’s disease drug carbidopa shows anticancer effects29 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
FDA approves Verzenio for metastatic breast cancer29 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)The FDA has approved Verzenio to treat advanced or metastatic breast cancer that has progressed after taking therapy...
EC grants marketing authorisation of Dupixent for atopic dermatitis28 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...
Ivermectin found to suppresses tumour development28 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
Smart capsules make water-soluble drug delivery possible28 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Scientists have combined a hydrophobic material polylactic acid and a biodegradable polymer calcium carbonate to encapsulate water-soluble drugs...
Vaccine demonstrates significant efficacy against severe rotavirus27 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis...
Genetic fault reduces the effectiveness of leukaemia treatment27 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
Wickham Laboratories announces successful MHRA GMP inspection27 September 2017 | By Wickham LaboratoriesWickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of GMP accreditation...
CYC065-eribulin combination for triple-negative breast cancer identified27 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
